These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 28799510)

  • 41. Efficacy, safety, and tolerability of adjunctive brivaracetam for secondarily generalized tonic-clonic seizures: Pooled results from three Phase III studies.
    Moseley BD; Sperling MR; Asadi-Pooya AA; Diaz A; Elmouft S; Schiemann J; Whitesides J
    Epilepsy Res; 2016 Nov; 127():179-185. PubMed ID: 27608437
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Eslicarbazepine acetate exposure in pregnant women with epilepsy.
    Costa R; Magalhães LM; Graça J; Vieira M; Gama H; Moreira J; Rocha JF; Soares-da-Silva P
    Seizure; 2018 May; 58():72-74. PubMed ID: 29674237
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pharmacological interventions for epilepsy in people with intellectual disabilities.
    Beavis J; Kerr M; Marson AG
    Cochrane Database Syst Rev; 2007 Jul; (3):CD005399. PubMed ID: 17636795
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Concomitant therapy in people with epilepsy: potential drug-drug interactions and patient awareness.
    Eyal S; Rasaby S; Ekstein D
    Epilepsy Behav; 2014 Feb; 31():369-76. PubMed ID: 24211058
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficacy and tolerability of adjunctive brivaracetam in patients with prior antiepileptic drug exposure: A post-hoc study.
    Asadi-Pooya AA; Sperling MR; Chung S; Klein P; Diaz A; Elmoufti S; Schiemann J; Whitesides J
    Epilepsy Res; 2017 Mar; 131():70-75. PubMed ID: 28279891
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficacy of artisanal preparations of cannabidiol for the treatment of epilepsy: Practical experiences in a tertiary medical center.
    Porcari GS; Fu C; Doll ED; Carter EG; Carson RP
    Epilepsy Behav; 2018 Mar; 80():240-246. PubMed ID: 29429908
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Psychiatric side effects and antiepileptic drugs: Observations from prospective audits.
    Stephen LJ; Wishart A; Brodie MJ
    Epilepsy Behav; 2017 Jun; 71(Pt A):73-78. PubMed ID: 28551500
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Real life pharmaceutical treatment patterns for adult patients with focal epilepsy in Germany: a longitudinal and cross-sectional analysis of recently approved anti-epileptic drugs.
    Groth A; Wilke T; Borghs S; Gille P; Joeres L
    Ger Med Sci; 2017; 15():Doc09. PubMed ID: 28638313
    [No Abstract]   [Full Text] [Related]  

  • 49. Antiepileptic monotherapy in newly diagnosed focal epilepsy. A network meta-analysis.
    Lattanzi S; Zaccara G; Giovannelli F; Grillo E; Nardone R; Silvestrini M; Trinka E; Brigo F
    Acta Neurol Scand; 2019 Jan; 139(1):33-41. PubMed ID: 30194755
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The efficacy and safety of retigabine and other adjunctive treatments for refractory partial epilepsy: a systematic review and indirect comparison.
    Martyn-St James M; Glanville J; McCool R; Duffy S; Cooper J; Hugel P; Lane PW
    Seizure; 2012 Nov; 21(9):665-78. PubMed ID: 22902288
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Efficacy of antiepileptic drugs in the adjunctive treatment of refractory partial-onset seizures: Meta-analysis of pivotal trials.
    Slater J; Chung S; Huynh L; Duh MS; Gorin B; McMicken C; Ziemann A; Isojarvi J
    Epilepsy Res; 2018 Jul; 143():120-129. PubMed ID: 29784458
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Adjunctive brivaracetam in adults with uncontrolled focal epilepsy: results from a double-blind, randomized, placebo-controlled trial.
    Ryvlin P; Werhahn KJ; Blaszczyk B; Johnson ME; Lu S
    Epilepsia; 2014 Jan; 55(1):47-56. PubMed ID: 24256083
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Classic antiepileptic and new generation antiepileptic drugs: gender differences in effectiveness and adverse drug reactions].
    Falip M; Artazcoz L; de la Peña P; Pérez-Sempere A; Martín-Moro M; Codina M;
    Neurologia; 2005 Mar; 20(2):71-6. PubMed ID: 15726473
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A common reference-based indirect comparison meta-analysis of eslicarbazepine versus lacosamide as add on treatments for focal epilepsy.
    Brigo F; Trinka E; Bragazzi NL; Nardone R; Milan A; Grillo E
    Epilepsy Res; 2016 Nov; 127():12-18. PubMed ID: 27543806
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antiepileptic Drug Treatment in Children with Epilepsy.
    Rosati A; De Masi S; Guerrini R
    CNS Drugs; 2015; 29(10):847-63. PubMed ID: 26400189
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical efficacy and safety of the newer antiepileptic drugs as adjunctive treatment in adults with refractory partial-onset epilepsy: a meta-analysis of randomized placebo-controlled trials.
    Gao L; Xia L; Zhao FL; Li SC
    Epilepsy Res; 2013 Jan; 103(1):31-44. PubMed ID: 22776828
    [TBL] [Abstract][Full Text] [Related]  

  • 57. New developments in the management of partial-onset epilepsy: role of brivaracetam.
    Coppola G; Iapadre G; Operto FF; Verrotti A
    Drug Des Devel Ther; 2017; 11():643-657. PubMed ID: 28293101
    [TBL] [Abstract][Full Text] [Related]  

  • 58. An Updated Overview on Therapeutic Drug Monitoring of Recent Antiepileptic Drugs.
    Jacob S; Nair AB
    Drugs R D; 2016 Dec; 16(4):303-316. PubMed ID: 27766590
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Adjunctive lacosamide in clinical practice: sodium blockade with a difference?
    Stephen LJ; Kelly K; Parker P; Brodie MJ
    Epilepsy Behav; 2011 Nov; 22(3):499-504. PubMed ID: 21890421
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Antiepileptic drugs in North America].
    Akiyama T; Otsubo H
    Brain Nerve; 2010 May; 62(5):519-26. PubMed ID: 20450099
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.